Integrated Nano-Technologies is committed to providing field personnel with fast, accurate test results that can improve biological identification. INT was founded in 2000 by an interdisciplinary team of scientists and engineers to develop creative solutions for diagnostics sample processing. Through government funding and private investments, INT has developed a working electronic DNA sensor, a universal sample preparation system and a novel rotary valve disposable cartridge for automated processing of complex biological analysis. This working system is in validation studies with a number of commercial and government customers.

Integrated Nano-Technologies Leadership (INT)
INT is led by Chairman and CEO D. Michael Connolly, supported by a board of legal, financial, scientific, military and medical experts. Their involvement ensures that INT develops the Palladium™ System to meet current and emerging market needs, on a sound corporate footing.

Intellectual Property
Integrated Nano-Technologies (INT) is pursuing an aggressive patent strategy within the US and key global markets. In addition to the issued patents, the company has over 40 patents pending to cover the processes, chemical compounds and novel designs behind its technology

Investor Relations
Integrated Nano-Technologies, LLC (INT) is a privately held New York Limited Liability Company, supported by private investors and funding from a number of government agencies. INT has a long track record of successful partnerships. INT also hopes to partner with foundations to make an impact on disease management in developing nations.